Yuting Ma

2428 Yuhe Road
Weifang, 261031, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Molecular mechanisms of α-conotoxin [S9K]TxID selectively targeting the rat α3β4 nicotinic acetylcholine receptor.

Molecular mechanisms of α-conotoxin [S9K]TxID selectively targeting the rat α3β4 nicotinic acetylcholine receptor.

Journal: International journal of biological macromolecules

Published: March 31, 2025

Single Amino Acid Substitution in Loop1 Switches the Selectivity of α-Conotoxin RegIIA towards the α7 Nicotinic Acetylcholine Receptor.

Single Amino Acid Substitution in Loop1 Switches the Selectivity of α-Conotoxin RegIIA towards the α7 Nicotinic Acetylcholine Receptor.

Journal: Marine drugs

Published: August 04, 2024

Identification of Potential Indicators for Survival in Patients with Thyroid Cancer Based on Expression of FAM3 Members.

Identification of Potential Indicators for Survival in Patients with Thyroid Cancer Based on Expression of FAM3 Members.

Journal: Critical reviews in eukaryotic gene expression

Published: May 15, 2023

Integrated multi-omics analyses reveal effects of empagliflozin on intestinal homeostasis in high-fat-diet mice.

Integrated multi-omics analyses reveal effects of empagliflozin on intestinal homeostasis in high-fat-diet mice.

Journal: iScience

Published: September 26, 2022

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease.

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease.

Journal: Frontiers in pharmacology

Published: May 16, 2022

Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1-Adiponectin Axis.

Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1-Adiponectin Axis.

Journal: Frontiers in endocrinology

Published: March 30, 2022

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease.

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease.

Journal: Frontiers in pharmacology

Published: October 12, 2021

Growth differentiation factor 11: a "rejuvenation factor" involved in regulation of age-related diseases?

Growth differentiation factor 11: a "rejuvenation factor" involved in regulation of age-related diseases?

Journal: Aging

Published: December 08, 2020

Liraglutide improves obesity-induced renal injury by alleviating uncoupling of the glomerular VEGF-NO axis in obese mice.

Liraglutide improves obesity-induced renal injury by alleviating uncoupling of the glomerular VEGF-NO axis in obese mice.

Journal: Clinical and experimental pharmacology & physiology

Published: May 03, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026